In-hospital mortality of elderly patients with acute myocardial infarction: Data from the mitra (Maximal Individual Therapy in Acute Myocardial Infarction) registry

Clinical Cardiology

Volumn 23, Issue 11, 2000, Pages 831-836

  Haase, K K ^a   Schiele, R ^a   Wagner, S ^a   Fischer, F ^a   Burczyk, U ^a   Zahn, R ^a   Schuster, S ^a   Senges, J ^a  

^a Heart Center Ludwigshafen   (Germany)

Author keywords

Acute myocardial infarction; Age; Early therapy

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HEART CATHETERIZATION; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATION; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; REGISTER; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT CONTRAINDICATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CEREBROVASCULAR ACCIDENT; FEMALE; GERMANY; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDIAL INFARCTION; REGISTRIES; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0033767206     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960231109     Document Type: Article

References (19)

1. Age-related increase in mortality among patients with first myocardial infarction treated with thrombolysis
2. Variation in the use of cardiac procedures after acute myocardial infarction
3. Impact of clinical trials on clinical practice: Example of thrombolysis for acute myocardial infarction
4. Long-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study
5. ISIS-2: Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
6. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction
7. Effect on mortality of metoprolol in acute myocardial infarction, a double-blind randomized trial
8. Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction
9. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
10. Effects of early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the Cooperative North Scandinavian Enalapril Survival Study II (Consensus II)
11. The 60 Minutes Myocardial Infarction Project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany
12. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
13. GISSI-2 A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction
14. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group ISIS-3: A randomized comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and or aspirin plus heparin vs. aspirin alone among 41,299 cases of suspected myocardial infarction
15. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial
16. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction. A report from the second National Registry of Myocardial Infarction (NRMI-2)
17. Thrombolytic therapy for elderly patients
18. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
19. Management of myocardial infarction: The proper priorities